[Expression of Girdin in brain tissues of Alzheimer's disease]

Zhonghua Bing Li Xue Za Zhi. 2015 May;44(5):301-4.
[Article in Chinese]

Abstract

Objective: To investigate the expression of Girdin and its significance in Alzheimer's disease (AD).

Methods: Fifty-nine autopsy cases from Department of Pathology, Beijing Hospital from January 1988 to December 2013, including 35 AD cases and 24 non-AD cases as control. Girdin and amyloid β-protein (Aβ) expression was evaluated immunohistochemically by EnVision method. The correlation between Girdin and Aβ was analyzed.

Results: Girdin expression was localized in the nucleus and/or cytoplasm. The expression rates of Girdin were 20.0% (7/35) in the AD group and 83.3% (20/24) in the non-AD group, respectively. The difference was significant (Yates's correction for continuity χ(2)=20.527, P<0.05). Girdin expression and Aβ deposition also correlated significantly (P<0.05).

Conclusions: Girdin shows reduced expression in AD, and is correlated positively with Aβ deposition. This suggests that Girdin may play an important role in the occurrence and development of AD.

MeSH terms

  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / pathology
  • Amyloid beta-Peptides / metabolism*
  • Autopsy
  • Brain / metabolism*
  • Brain / pathology
  • Humans
  • Microfilament Proteins / metabolism*
  • Vesicular Transport Proteins / metabolism*

Substances

  • Amyloid beta-Peptides
  • CCDC88A protein, human
  • Microfilament Proteins
  • Vesicular Transport Proteins